These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 527347)
1. Aerosolized clenbuterol (NAB 365) and salbutamol in exercise-induced asthma. Del Bono N; Quartieri F; Vibelli C Curr Med Res Opin; 1979; 6(4):237-43. PubMed ID: 527347 [TBL] [Abstract][Full Text] [Related]
2. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial. Pasotti C; Capra A; Vibelli C Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459 [TBL] [Abstract][Full Text] [Related]
3. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. Baronti A; Grieco A; Vibelli C Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the protective effect and duration of action of orally administered clenbuterol and salbutamol on exercise-induced asthma in children. Boner AL; Vallone G; Brighenti C; Schiassi M; Miglioranzi P; Richelli C Pediatr Pulmonol; 1988; 4(4):197-200. PubMed ID: 3393382 [TBL] [Abstract][Full Text] [Related]
5. A trial of clenbuterol in bronchial asthma. Anderson G; Wilkins E Thorax; 1977 Dec; 32(6):717-9. PubMed ID: 341407 [TBL] [Abstract][Full Text] [Related]
6. Comparison of NAB 365 and salbutamol tablets in chronic bronchitis and asthma. Cummiskey J; Keelan P; Gray P; Cox GA Ir Med J; 1978 Mar; 71(4):123-6. PubMed ID: 344272 [No Abstract] [Full Text] [Related]
7. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction. Jaffé G; Grimshaw JJ Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806 [TBL] [Abstract][Full Text] [Related]
8. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol. Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526 [TBL] [Abstract][Full Text] [Related]
9. Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Papiris S; Galavotti V; Sturani C Respiration; 1986; 49(2):101-8. PubMed ID: 3513269 [TBL] [Abstract][Full Text] [Related]
10. Intravenous NAB 365 (clenbuterol) and terbutaline in exercise-induced bronchospasm (EIB). Del Bono N; Quartieri F; Vibelli C Clin Allergy; 1979 May; 9(3):277-82. PubMed ID: 466753 [TBL] [Abstract][Full Text] [Related]
11. [Comparative study of clenbuterol and salbutamol in the clinical control of the intercritical period in patients with recurrent bronchial asthma]. Castelán Montalvo FA; Martínez Hernández G; Palmeros L Rev Alerg Mex (1987); 1989; 36(1):28-30. PubMed ID: 2749126 [No Abstract] [Full Text] [Related]
12. Salmefamol and Salbutamol in exercise-induced asthma in children. Hills EA; Davies S; Geary M Br J Dis Chest; 1976 Apr; 70(2):78-82. PubMed ID: 8070 [TBL] [Abstract][Full Text] [Related]
13. Double-blind cross-over comparison of clenbuterol and salbutamol tablets in asthmatic out-patients. Salorinne Y; Stenius B; Tukiainen P; Poppius H Eur J Clin Pharmacol; 1975 Apr; 8(3-4):189-95. PubMed ID: 9295 [TBL] [Abstract][Full Text] [Related]
14. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. Boner AL; Sette L; Castellani C; Schiassi M J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140 [TBL] [Abstract][Full Text] [Related]
15. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. Henriksen JM; Agertoft L; Pedersen S J Allergy Clin Immunol; 1992 Jun; 89(6):1176-82. PubMed ID: 1351489 [TBL] [Abstract][Full Text] [Related]
16. [Effect of clenbuterol in asthma induced by exercise in children]. Salvadó A; Yáñez M; Robles B Rev Chil Pediatr; 1985; 56(1):38-41. PubMed ID: 4081177 [No Abstract] [Full Text] [Related]
17. Study of the cardiovascular effects of clenbuterol in exercise-induced asthma. Di Gioacchino M; Mezzetti A; Mancini M; Guglielmi MD; Lo Medico E; Proietti Franceschilli G; Marzio L; Cuccurullo F Respiration; 1987; 51(3):205-13. PubMed ID: 3602593 [TBL] [Abstract][Full Text] [Related]
18. [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma]. Yamamoto H; Nagata M; Tabe K; Suzuki S; Maruo H; Sakamoto Y; Yamamoto K; Dohi Y Arerugi; 1990 Jan; 39(1):21-7. PubMed ID: 1972011 [TBL] [Abstract][Full Text] [Related]
19. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma. Beumer HM Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220 [TBL] [Abstract][Full Text] [Related]
20. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma. Becker AB; Simons FE J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]